Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05499468 · ClinicalTrials.gov registry record · NA
Evaluating a Physician Opinion Leader Intervention to Increase Utilization of Coaching/Therapy During Residency
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 493
- Enrollment target
NCT05499468: Completed NA study, sponsored by Stanford University.
NCT05499468 is a NA study that has completed, run by Stanford University. The registered enrollment target is 493 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05499468, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 493 participants
- Enrollment target
Study Summary
Investigators will assess the efficacy of a physician popular opinion leader-led intervention to increase awareness and utilization of existing evidence-based coaching or therapy among post-graduate clinical trainees at Stanford.
Primary Outcome
The WellConnect service tracks utilization by residents in each department. The study team will ask WellConnect to report the total number of calls from November 1, 2021, through June 30th 2022, from house-staff (residents and fellows) who are part of training programs that participated in the POL program. The proportion of residents in each program who participate in coaching or psychotherapy support offered by the WellConnect program will be calculated by dividing the number of residents who p
Interventions
- OTHER Popular-Opinion Leader-led encouragement during training meetings and informal conversation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 493 participants |
| Start Date | 2022-08-30 |
| Est. Completion | 2022-10-11 |
| Phase | NA |
What the finished NCT05499468 record still lists
NCT05499468 is an interventional study that assigns participants to a tested intervention. The registered 493 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which Popular-Opinion Leader-led encouragement during training meetings and informal conversation is the first listed.
NCT05499468 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05499468 about?
NCT05499468 is a clinical study titled "Evaluating a Physician Opinion Leader Intervention to Increase Utilization of Coaching/Therapy During Residency". Investigators will assess the efficacy of a physician popular opinion leader-led intervention to increase awareness and utilization of existing evidence-based coaching or therapy among post-graduate clinical trainees at Stanford.
What is the current status of trial NCT05499468?
This trial is currently completed. It is a NA study. The enrollment target is 493 participants. The study started on 2022-08-30. Estimated completion is 2022-10-11.
What interventions are being tested in trial NCT05499468?
The interventions under investigation include: Popular-Opinion Leader-led encouragement during training meetings and informal conversation (OTHER).
Who is sponsoring clinical trial NCT05499468?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05499468's enrollment target sits among peer trials
493 213th of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05861973 · 492 participants · NA
SMARTer Weight Loss Management
- NCT05908331 · 492 participants · NA
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NCT06152575 · 492 participants · Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- NCT06953089 · 492 participants · Phase 2
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI